About: Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 September 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en setiembre de 2020 (ast) наукова стаття, опублікована 15 вересня 2020 (uk) scientific article published on 15 September 2020 (en)
publication date	wds:Q99546939-8B0E7EE7-D507-4F70-8A45-6873E84B3985
publication date	2020-09-15 00:00:00Z (xsd:dateTime)
cites work	wds:Q99546939-1228BD18-E5BC-4A11-A227-11E5862C5374 wds:Q99546939-12A07126-3101-4E73-BD98-D56D575F88E4 wds:Q99546939-55F075A3-E689-4DC4-8067-CA3AD0735172 wds:Q99546939-7E6D1108-C216-46C7-9F22-C79AFBA6C7AC wds:Q99546939-90AACCD2-7FE5-4DE6-A65F-92D0A81A89E7 wds:Q99546939-B11A93B6-8055-4E0E-A6CE-4CB7D1BF377C wds:Q99546939-B1A311A4-C1CD-48B9-ABE6-714D447DA67B wds:Q99546939-BB6F6AC3-D18A-480A-91E6-4DE8F8F160A5 wds:Q99546939-D0AD9F4C-7FEE-462A-959D-36CE9452E753 wds:Q99546939-D41805B7-0206-417D-8DA1-8993AC0573AD wds:Q99546939-F6EF828F-9E80-4902-9E6F-7E0264E298BD wds:Q99546939-F7D4A6AE-DE1D-4FD8-ABD6-64982C34909B
cites work	Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019 Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies COVID-19 update: Covid-19-associated coagulopathy Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19 Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor? If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis Anti-Xa assays: What is their role today in antithrombotic therapy?
author name string	wds:Q99546939-1B96AAF7-EB36-4D3A-A5E5-1B166FBB0EDE wds:Q99546939-24ABF067-700F-4F2E-ACC0-E5474D0DFDF4 wds:Q99546939-2B7D034C-A2E9-4143-8761-97EE26C16FC7 wds:Q99546939-680D5CE8-4F9A-4D09-BBDE-EF992BB70F6F wds:Q99546939-886CD5F7-A456-4DF4-91AA-1FE7D63378C3 wds:Q99546939-92AC9A0E-685F-47C2-A8FE-26D1BE0929DD wds:Q99546939-CB065E02-9AEA-403F-8112-1279EB40A0C2 wds:Q99546939-F81D1BBD-C019-48B2-9A39-49F62EF48618
author name string	Anthony P Pietropaoli Christine M Groth David C Kaufman Caroline M Quill Paritosh Prasad Jenna M Clark Kaylee M Maynard Samantha Delibert
rdfs:label	Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 (en) Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 (nl)
skos:prefLabel	Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 (en) Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 (nl)
name	Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 (en) Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 (nl)
author	wds:Q99546939-C4343248-C97A-4C5F-A5CF-B789AA2F0C92
author	Stephen H Rappaport
title	wds:Q99546939-6C68909E-AFD7-4AEE-A327-589D8CBEB236
title	Anti-FXa Activity with Intermediate Dose Thromboprophylaxis in COVID-19 (en)
instance of	wds:Q99546939-87FFA72B-A7DB-4589-8C19-4DAE3E4D4AE5
instance of	scholarly article
main subject	wds:Q99546939-3CFDB40C-2F01-4446-B270-D30B0FB38639
main subject	COVID-19 mortality
PubMed ID	wds:Q99546939-68E198B3-72D2-405C-95CC-29A006FD4E9F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32931713
PubMed ID	32931713
published in	wds:Q99546939-F417ED89-A184-4638-8C46-A29289EF3B3B
published in	American Journal of Respiratory and Critical Care Medicine
DOI	wds:Q99546939-B4F1E151-E4C0-40BD-B87D-3FE2A1999083
DOI	http://dx.doi.org/10.1164/RCCM.202006-2511LE
DOI	10.1164/RCCM.202006-2511LE
PMCID	wds:Q99546939-CBA1A685-807E-4441-8151-B41B20D0B2EA
PMCID	7737599
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q99546939

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software